{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:40:47Z","timestamp":1792489247357,"version":"4.5.0"},"reference-count":91,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10200012320013"],"award-info":[{"award-number":["10200012320013"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Palliat Med"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Patients with palliative needs often use potentially inappropriate medications, leading to adverse health outcomes. Deprescribing remains poorly enacted in primary care. Understanding the factors influencing deprescribing is essential for successful implementation into clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To explore factors influencing deprescribing in community-dwelling patients with palliative needs in primary care from the perspectives of patients, their caregivers and primary healthcare practitioners.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Qualitative systematic review using thematic synthesis, registered in PROSPERO (CRD42024620219).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources:<\/jats:title>\n                    <jats:p>MEDLINE, Embase, CINAHL, and PsycINFO were searched from 2000 to January 2025, directed by the Palliative cAre Literature rEview iTeraTive mEthod (PALETTE) framework. Studies were included if they reported on independently living adults with palliative care needs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>23 studies were included. Four themes were established: (i) initial stance towards deprescribing: shaped by values, general perceptions of (de)prescribing, and competencies. This served as the premise for (ii) the deprescribing conversation: characterised by an individualised deliberation, shared decision-making, and tailored communication and practical strategies. During this conversation, (de)prescribing was reconsidered in the context of the individual patient, informing final decisions. Whether and how these conversations occurred was dependent on (iii) organisational factors, including systematic work processes and interprofessional collaboration. All factors operated within and interacted with (iv) the context of care, containing system-level prerequisites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Deprescribing in community-dwelling patients with palliative needs in primary care can be optimised by employing a multidimensional strategy that includes patient-centredness, shared decision-making, education, collaboration within the multidisciplinary care team, and systematic work processes, ultimately aiming to improve quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02692163261465769","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:52:32Z","timestamp":1785484352000},"page":"1270-1288","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors influencing deprescribing in community-dwelling patients with palliative needs in primary care: A qualitative systematic review"],"prefix":"10.1177","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5631-3761","authenticated-orcid":false,"given":"Jesse F.","family":"van Weelderen","sequence":"first","affiliation":[{"name":"Centre of Expertise in Palliative Care Utrecht, Julius Centre for Health Sciences and Primary Care, Department of General Practice &amp; Nursing Science, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankie C. M.","family":"Hazen","sequence":"additional","affiliation":[{"name":"Centre of Expertise in Palliative Care Utrecht, Julius Centre for Health Sciences and Primary Care, Department of General Practice &amp; Nursing Science, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa M. M.","family":"Mulder","sequence":"additional","affiliation":[{"name":"Centre of Expertise in Palliative Care Utrecht, Julius Centre for Health Sciences and Primary Care, Department of General Practice &amp; Nursing Science, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7354-2220","authenticated-orcid":false,"given":"Eric C. T.","family":"Geijteman","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia C. C. M.","family":"Teunissen","sequence":"additional","affiliation":[{"name":"Centre of Expertise in Palliative Care Utrecht, Julius Centre for Health Sciences and Primary Care, Department of General Practice &amp; Nursing Science, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien L. M.","family":"Zwart","sequence":"additional","affiliation":[{"name":"Centre of Expertise in Palliative Care Utrecht, Julius Centre for Health Sciences and Primary Care, Department of General Practice &amp; Nursing Science, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Grant","sequence":"additional","affiliation":[{"name":"Centre of Expertise in Palliative Care Utrecht, Julius Centre for Health Sciences and Primary Care, Department of General Practice &amp; Nursing Science, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","unstructured":"McNeil MJ Kamal AH Kutner JS et al. The burden of polypharmacy in patients near the end of life. J Pain Symptom Manage 2016; 51: 178\u2013183.e172. https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.09.003","DOI":"10.1016\/j.jpainsymman.2015.09.003"},{"key":"e_1_3_3_3_2","unstructured":"IKNL \/ Palliactief. Kwaliteitskader palliatieve zorg Nederland. 2017 https:\/\/palliaweb.nl\/richtlijnen-palliatieve-zorg\/richtlijn\/kwaliteitskader-palliatieve-zorg-nederland (2017 accessed 22 July 2025)."},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","unstructured":"Pype P Mertens F Helewaut F et al. Potentially inappropriate medication in primary care at the end of life: a mixed-method study. Acta Clin Belg 2018; 73: 213\u2013219. https:\/\/doi.org\/10.1080\/17843286.2017.1410606","DOI":"10.1080\/17843286.2017.1410606"},{"key":"e_1_3_3_5_2","doi-asserted-by":"crossref","unstructured":"Holmes HM Hayley DC Alexander GC et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006; 166: 605\u2013609. https:\/\/doi.org\/10.1001\/archinte.166.6.605","DOI":"10.1001\/archinte.166.6.605"},{"key":"e_1_3_3_6_2","doi-asserted-by":"crossref","unstructured":"Lavan AH Gallagher P Parsons C et al. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing 2017; 46: 600\u2013607. https:\/\/doi.org\/10.1093\/ageing\/afx005","DOI":"10.1093\/ageing\/afx005"},{"key":"e_1_3_3_7_2","doi-asserted-by":"crossref","unstructured":"Schenker Y Park SY Jeong K et al. Associations between polypharmacy symptom burden and quality of life in patients with advanced life-limiting illness. J Gen Intern Med 2019; 34: 559\u2013566. https:\/\/doi.org\/10.1007\/s11606-019-04837-7","DOI":"10.1007\/s11606-019-04837-7"},{"key":"e_1_3_3_8_2","doi-asserted-by":"crossref","unstructured":"Drenth-Van Maanen AC Wilting I Jansen PAF. Prescribing medicines to older people\u2014how to consider the impact of ageing on human organ and body functions. Br J Clin Pharmacol 2020; 86: 1921\u20131930. https:\/\/doi.org\/10.1111\/bcp.14094","DOI":"10.1111\/bcp.14094"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","unstructured":"Stevenson J Abernethy AP Miller C et al. Managing comorbidities in patients at the end of life. BMJ 2004; 329: 909\u2013912. https:\/\/doi.org\/10.1136\/bmj.329.7471.909","DOI":"10.1136\/bmj.329.7471.909"},{"key":"e_1_3_3_10_2","doi-asserted-by":"crossref","unstructured":"Leblanc TW McNeil MJ Kamal AH et al. Polypharmacy in patients with advanced cancer and the role of medication discontinuation. Lancet Oncol 2015; 16: e333\u2013e341. https:\/\/doi.org\/10.1016\/s1470-2045(15)00080-7","DOI":"10.1016\/S1470-2045(15)00080-7"},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","unstructured":"Jaramillo-Hidalgo J Lozano-Montoya I Tornero-Torres O et al. Prevalence of potentially inappropriate prescription in community-dwelling patients with advanced dementia and palliative care needs. Rev Esp Geriatr Gerontol 2021; 56: 203\u2013207. https:\/\/doi.org\/10.1016\/j.regg.2021.03.001","DOI":"10.1016\/j.regg.2021.03.001"},{"key":"e_1_3_3_12_2","doi-asserted-by":"crossref","unstructured":"Reeve E Gnjidic D Long J et al. A systematic review of the emerging definition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol 2015; 80: 1254\u20131268. https:\/\/doi.org\/10.1111\/bcp.12732","DOI":"10.1111\/bcp.12732"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","unstructured":"Shrestha S Poudel A Steadman K et al. Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: a systematic review. Br J Clin Pharmacol 2020; 86: 1931\u20131945. https:\/\/doi.org\/10.1111\/bcp.14113","DOI":"10.1111\/bcp.14113"},{"key":"e_1_3_3_14_2","unstructured":"World Health Organization. Palliative Care https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/palliative-care (2020 accessed 17 March 2026)."},{"key":"e_1_3_3_15_2","doi-asserted-by":"crossref","unstructured":"Antonisse A Van Der Baan FH Grant M et al. Use of preventive medication and supplements in general practice in patients in their last year of life: a retrospective cohort study. BMC Prim Care 2023; 24: 101. https:\/\/doi.org\/10.1186\/s12875-023-02049-x.","DOI":"10.1186\/s12875-023-02049-x"},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","unstructured":"Gillespie RJ Harrison L Mullan J. Deprescribing medications for older adults in the primary care context: a mixed studies review. Health Sci Rep 2018; 1: e45. https:\/\/doi.org\/10.1002\/hsr2.45","DOI":"10.1002\/hsr2.45"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","unstructured":"Paque K Vander Stichele R Elseviers M et al. Barriers and enablers to deprescribing in people with a life-limiting disease: a systematic review. Palliat Med 2019; 33: 37\u201348. 20180919. https:\/\/doi.org\/10.1177\/0269216318801124","DOI":"10.1177\/0269216318801124"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","unstructured":"Lundby C Graab\u00e6k T Ryg J et al. Health care professionals\u2019 attitudes towards deprescribing in older patients with limited life expectancy: a systematic review. Br J Clin Pharmacol 2019; 85: 868\u2013892. https:\/\/doi.org\/10.1111\/bcp.13861","DOI":"10.1111\/bcp.13861"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","unstructured":"Burghle A Lundby C Ryg J et al. Attitudes towards deprescribing among older adults with limited life expectancy and their relatives: a systematic review. Drugs Aging 2020; 37: 503\u2013520. https:\/\/doi.org\/10.1007\/s40266-020-00774-x","DOI":"10.1007\/s40266-020-00774-x"},{"key":"e_1_3_3_20_2","doi-asserted-by":"crossref","unstructured":"Doherty AJ Boland P Reed J et al. Barriers and facilitators to deprescribing in primary care: a systematic review. BJGP Open 2020; 4: bjgpopen20X1010. https:\/\/doi.org\/10.3399\/bjgpopen20x101096","DOI":"10.3399\/bjgpopen20X101096"},{"key":"e_1_3_3_21_2","doi-asserted-by":"crossref","unstructured":"Bokhof B Junius-Walker U. Reducing polypharmacy from the perspectives of general practitioners and older patients: a synthesis of qualitative studies. DrugsAging 2016; 33: 249\u2013266. https:\/\/doi.org\/10.1007\/s40266-016-0354-5","DOI":"10.1007\/s40266-016-0354-5"},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","unstructured":"Sundell K Beelmann A Hasson H et al. Novel programs international adoptions or contextual adaptations? Meta-analytical results from German and Swedish intervention research. J Clin Child Adolesc Psychol 2016; 45: 784\u2013796. https:\/\/doi.org\/10.1080\/15374416.2015.1020540","DOI":"10.1080\/15374416.2015.1020540"},{"key":"e_1_3_3_23_2","doi-asserted-by":"crossref","unstructured":"Thomas J Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol 2008; 8: 45. https:\/\/doi.org\/10.1186\/1471-2288-8-45","DOI":"10.1186\/1471-2288-8-45"},{"key":"e_1_3_3_24_2","doi-asserted-by":"crossref","unstructured":"Moher D Liberati A Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 6(7): e1000097. https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00135","DOI":"10.1371\/journal.pmed.1000097"},{"key":"e_1_3_3_25_2","doi-asserted-by":"crossref","unstructured":"Shamseer L Moher D Clarke M et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015; 349: g7647. https:\/\/doi.org\/10.1136\/bmj.g7647","DOI":"10.1136\/bmj.g7647"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","unstructured":"Tong A Flemming K McInnes E et al. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol 2012; 12: 181. https:\/\/doi.org\/10.1186\/1471-2288-12-181","DOI":"10.1186\/1471-2288-12-181"},{"key":"e_1_3_3_27_2","first-page":"105","volume-title":"Handbook of qualitative research","author":"Guba E","year":"1994","unstructured":"Guba E, Lincoln Y. Competing paradigms in qualitative research. In: Denzin N, Lincoln Y (eds) Handbook of qualitative research. Sage Publications, 1994, pp.105\u2013117."},{"key":"e_1_3_3_28_2","doi-asserted-by":"crossref","unstructured":"Zwakman M Verberne LM Kars MC et al. Introducing PALETTE: an iterative method for conducting a literature search for a review in palliative care. BMC Palliat Care 2018; 17: 82. https:\/\/doi.org\/10.1186\/s12904-018-0335-z","DOI":"10.1186\/s12904-018-0335-z"},{"key":"e_1_3_3_29_2","doi-asserted-by":"crossref","unstructured":"Porritt K Evans C Bennett C et al. Systematic reviews of qualitative evidence (2024). Aromataris E Lockwood C Porritt K et al. editors. JBI Manual for Evidence Synthesis. JBI; 2024. https:\/\/doi.org\/10.46658\/JBIMES-24-02","DOI":"10.46658\/JBIMES-24-02"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","unstructured":"Rietjens JA Bramer WM Geijteman EC et al. Development and validation of search filters to find articles on palliative care in bibliographic databases. Palliat Med 2019; 33: 470\u2013474. https:\/\/doi.org\/10.1177\/0269216318824275","DOI":"10.1177\/0269216318824275"},{"key":"e_1_3_3_31_2","unstructured":"FMD(3S) CHLA. Recherche quallitative https:\/\/extranet.santecom.qc.ca\/wiki\/!biblio3s\/doku.php?id=concepts:recherche-qualitative (accessed 10 December 2024)."},{"key":"e_1_3_3_32_2","doi-asserted-by":"crossref","unstructured":"Pols DHJ Bramer WM Bindels PJE et al. Development and validation of search filters to identify articles on family medicine in online medical databases. Ann Fam Med 2015; 13: 364\u2013366. https:\/\/doi.org\/10.1370\/afm.1780","DOI":"10.1370\/afm.1780"},{"key":"e_1_3_3_33_2","doi-asserted-by":"crossref","unstructured":"Morel T Nguyen-Soenen J Thompson W et al. Development and validation of search filters to identify articles on deprescribing in Medline and Embase. BMC Med Res Methodol 2022; 22: 79. https:\/\/doi.org\/10.1186\/s12874-022-01515-x","DOI":"10.1186\/s12874-022-01515-x"},{"key":"e_1_3_3_34_2","doi-asserted-by":"crossref","unstructured":"Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res 2003; 33: 323\u2013328. https:\/\/doi.org\/10.1002\/jppr2003334323","DOI":"10.1002\/jppr2003334323"},{"key":"e_1_3_3_35_2","doi-asserted-by":"crossref","unstructured":"Booth A. Searching for qualitative research for inclusion in systematic reviews: a structured methodological review. Syst Rev 2016; 5: 74. https:\/\/doi.org\/10.1186\/s13643-016-0249-x","DOI":"10.1186\/s13643-016-0249-x"},{"key":"e_1_3_3_36_2","unstructured":"Critical Appraisal Skills Programme. CASP Qualitative Studies Checklist https:\/\/casp-uk.net\/casp-tools-checklists\/qualitative-studies-checklist\/ (2024 accessed 11 February 2025)."},{"key":"e_1_3_3_37_2","unstructured":"Hong QN Pluye P F\u00e0bregues S et al. Mixed Methods Appraisal Tool (MMAT) version 2018. Registration of Copyright (#1148552) Canadian Intellectual Property Office Industry Canada."},{"key":"e_1_3_3_38_2","doi-asserted-by":"crossref","unstructured":"Cortis L. A qualitative study to describe patient-specific factors that relate to clinical need for and potential to benefit from a medication management service in palliative care J Pharm Pract Res 2017: 34\u201340. https:\/\/doi.org\/10.1002\/jppr.1147","DOI":"10.1002\/jppr.1147"},{"key":"e_1_3_3_39_2","doi-asserted-by":"crossref","unstructured":"Kuruvilla L Weeks G Eastman P et al. Medication management for community palliative care patients and the role of a specialist palliative care pharmacist: a qualitative exploration of consumer and health care professional perspectives. Palliat Med 2018; 32: 1369\u20131377. https:\/\/doi.org\/10.1177\/0269216318777390","DOI":"10.1177\/0269216318777390"},{"key":"e_1_3_3_40_2","doi-asserted-by":"crossref","unstructured":"Mc Namara KP Breken BD Alzubaidi HT et al. Health professional perspectives on the management of multimorbidity and polypharmacy for older patients in Australia. Age Ageing 2017; 46(2): 291\u2013299. https:\/\/doi.org\/10.1093\/ageing\/afw200","DOI":"10.1093\/ageing\/afw200"},{"key":"e_1_3_3_41_2","doi-asserted-by":"crossref","unstructured":"Lundby C Graab\u00e6k T Ryg J et al. \u201c. . . Above all it\u2019s a matter of this person\u2019s quality of life\u201d: health care professionals\u2019 perspectives on deprescribing in older patients with limited life expectancy. Gerontologist 2020; 60: 439\u2013449. https:\/\/doi.org\/10.1093\/geront\/gnz116","DOI":"10.1093\/geront\/gnz116"},{"key":"e_1_3_3_42_2","doi-asserted-by":"crossref","unstructured":"Alwidyan T McCorry NK Parsons C. Healthcare professionals\u2019 perspectives of deprescribing in older patients at the end of life in hospice care: a qualitative study using the Theoretical Domains Framework. Int J Pharm Pract 2023; 31: 305\u2013313. https:\/\/doi.org\/10.1093\/ijpp\/riad005","DOI":"10.1093\/ijpp\/riad005"},{"key":"e_1_3_3_43_2","doi-asserted-by":"crossref","unstructured":"McCloskey B Hughes C Parsons C. A qualitative exploration of proxy decision makers\u2019 expectations of prescribed medications for people with advanced dementia. Palliat Med 2018; 32: 1114\u20131123. https:\/\/doi.org\/10.1177\/0269216318757163","DOI":"10.1177\/0269216318757163"},{"key":"e_1_3_3_44_2","doi-asserted-by":"crossref","unstructured":"Parsons C McCorry N Murphy K et al. Assessment of factors that influence physician decision making regarding medication use in patients with dementia at the end of life. Int J Geriatr Psychiatry 2014; 29: 281\u2013290. https:\/\/doi.org\/10.1002\/gps.4006","DOI":"10.1002\/gps.4006"},{"key":"e_1_3_3_45_2","doi-asserted-by":"crossref","unstructured":"Sand AM Harris J Rosland JH. Living with advanced cancer and short life expectancy: patients\u2019 experiences with managing medication. J Palliat Care 2009; 25: 85\u201391. https:\/\/doi.org\/10.1177\/082585970902500202","DOI":"10.1177\/082585970902500202"},{"key":"e_1_3_3_46_2","doi-asserted-by":"crossref","unstructured":"Dees MK Geijteman ECT Dekkers WJM et al. Perspectives of patients close relatives nurses and physicians on end-of-life medication management. Palliat Support Care 2018; 16: 580\u2013589. https:\/\/doi.org\/10.1017\/s1478951517000761","DOI":"10.1017\/S1478951517000761"},{"key":"e_1_3_3_47_2","doi-asserted-by":"crossref","unstructured":"Geijteman ECT MK Dees Tempelman MMA et al. Understanding the continuation of potentially inappropriate medications at the end of life: perspectives from individuals and their relatives and physicians. J Am Geriatr Soc 2016; 64: 2602\u20132604. https:\/\/doi.org\/10.1111\/jgs.14519","DOI":"10.1111\/jgs.14519"},{"key":"e_1_3_3_48_2","doi-asserted-by":"crossref","unstructured":"Huisman BAA ECT Geijteman Arevalo JJ et al. Use of antithrombotics at the end of life: an in-depth chart review study. BMC Palliat Care 2021; 20: 110. https:\/\/doi.org\/10.1186\/s12904-021-00786-3","DOI":"10.1186\/s12904-021-00786-3"},{"key":"e_1_3_3_49_2","doi-asserted-by":"crossref","unstructured":"Huisman BAA ECT Geijteman Dees MK et al. Role of nurses in medication management at the end of life: a qualitative interview study. BMC Palliat Care 2020; 19: 68. https:\/\/doi.org\/10.1186\/s12904-020-00574-5","DOI":"10.1186\/s12904-020-00574-5"},{"key":"e_1_3_3_50_2","doi-asserted-by":"crossref","unstructured":"Huisman BAA ECT Geijteman Kolf N et al. Physicians\u2019 opinions on anticoagulant therapy in patients with a limited life expectancy. Semin Thromb Hemost 2021; 47: 735\u2013744. https:\/\/doi.org\/10.1055\/s-0041-1725115","DOI":"10.1055\/s-0041-1725115"},{"key":"e_1_3_3_51_2","doi-asserted-by":"crossref","unstructured":"Van Der Waal MS Teunissen SC Uyttewaal AG et al. Factors influencing deprescribing in primary care for those towards the end of life: a qualitative interview study with patients and healthcare practitioners. Palliat Med 2024; 38(8): 884\u2013892. https:\/\/doi.org\/10.1177\/02692163241261202","DOI":"10.1177\/02692163241261202"},{"key":"e_1_3_3_52_2","doi-asserted-by":"crossref","unstructured":"Van Middelaar T Ivens SD Van Peet PG et al. Prescribing and deprescribing antihypertensive medication in older people by Dutch general practitioners: a qualitative study. BMJ Open 2018; 8: e020871. https:\/\/doi.org\/10.1136\/bmjopen-2017-020871","DOI":"10.1136\/bmjopen-2017-020871"},{"key":"e_1_3_3_53_2","doi-asserted-by":"crossref","unstructured":"Parsons C Gamble S. Caregivers\u2019 perspectives and experiences of withdrawing acetylcholinesterase inhibitors and memantine in advanced dementia: a qualitative analysis of an online discussion forum. BMC Palliat Care 2019; 18: 6. https:\/\/doi.org\/10.1186\/s12904-018-0387-0","DOI":"10.1186\/s12904-018-0387-0"},{"key":"e_1_3_3_54_2","doi-asserted-by":"crossref","unstructured":"Robinson-Barella A Richardson CL Bayley Z et al. \u201cStarting to think that way from the start\u201d: approaching deprescribing decision-making for people accessing palliative care - a qualitative exploration of healthcare professionals views. BMC Palliat Care 2024; 23: 221. https:\/\/doi.org\/10.1186\/s12904-024-01523-2","DOI":"10.1186\/s12904-024-01523-2"},{"key":"e_1_3_3_55_2","doi-asserted-by":"crossref","unstructured":"Sheard L Prout H Dowding D et al. The ethical decisions UK doctors make regarding advanced cancer patients at the end of life - the perceived (in) appropriateness of anticoagulation for venous thromboembolism: a qualitative study. BMC Med Ethics 2012; 13: 22. https:\/\/doi.org\/10.1186\/1472-6939-13-22","DOI":"10.1186\/1472-6939-13-22"},{"key":"e_1_3_3_56_2","doi-asserted-by":"crossref","unstructured":"Todd A Holmes H Pearson S et al. \u2018I don\u2019t think I\u2019d be frightened if the statins went\u2019: a phenomenological qualitative study exploring medicines use in palliative care patients carers and healthcare professionals. BMC Palliat Care 2016; 15: 13. https:\/\/doi.org\/10.1186\/s12904-016-0086-7","DOI":"10.1186\/s12904-016-0086-7"},{"key":"e_1_3_3_57_2","doi-asserted-by":"crossref","unstructured":"Wyatt K Bastaki H Davies N. Delivering end-of-life care for patients with cancer at home: interviews exploring the views and experiences of general practitioners. Health Soc Care Community 2022; 30: e126\u2013e137. https:\/\/doi.org\/10.1111\/hsc.13419","DOI":"10.1111\/hsc.13419"},{"key":"e_1_3_3_58_2","doi-asserted-by":"crossref","unstructured":"Hall RK Rutledge J Lucas A et al. Stakeholder perspectives on factors related to deprescribing potentially inappropriate medications in older adults receiving dialysis. Clin J Am Soc Nephrol 2023; 18: 1310\u20131320. https:\/\/doi.org\/10.2215\/cjn.0000000000000229","DOI":"10.2215\/CJN.0000000000000229"},{"key":"e_1_3_3_59_2","doi-asserted-by":"crossref","unstructured":"Tjia J DeSanto-Madeya S Mazor KM et al. Nurses\u2019 perspectives on family caregiver medication management support and deprescribing. J Hosp Palliat Nurs 2019; 21: 312\u2013318. https:\/\/doi.org\/10.1097\/njh.0000000000000574","DOI":"10.1097\/NJH.0000000000000574"},{"key":"e_1_3_3_60_2","doi-asserted-by":"crossref","unstructured":"Reeve E Wolff JL Skehan M et al. Assessment of attitudes toward deprescribing in older medicare beneficiaries in the United States. JAMA Internal Medicine 2018; 178: 1673. https:\/\/doi.org\/10.1001\/jamainternmed.2018.4720","DOI":"10.1001\/jamainternmed.2018.4720"},{"key":"e_1_3_3_61_2","doi-asserted-by":"crossref","unstructured":"Lynn J Schall MW Milne C et al. Quality improvements in end of life care: insights from two collaboratives. Jt Comm J Qual Improv 2000; 26: 254\u2013267. https:\/\/doi.org\/10.1016\/s1070-3241(00)26020-3","DOI":"10.1016\/S1070-3241(00)26020-3"},{"key":"e_1_3_3_62_2","doi-asserted-by":"crossref","unstructured":"Highet G Crawford D Murray SA et al. Development and evaluation of the Supportive and Palliative Care Indicators Tool (SPICT): a mixed-methods study. BMJ Support Palliat Care 2014; 4: 285\u2013290. https:\/\/doi.org\/10.1136\/bmjspcare-2013-000488","DOI":"10.1136\/bmjspcare-2013-000488"},{"key":"e_1_3_3_63_2","doi-asserted-by":"crossref","unstructured":"Curtin D Gallagher P O\u2019Mahony D. Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2. Age Ageing 2021; 50: 465\u2013471. https:\/\/doi.org\/10.1093\/ageing\/afaa159","DOI":"10.1093\/ageing\/afaa159"},{"key":"e_1_3_3_64_2","doi-asserted-by":"crossref","unstructured":"Lindsay J Dooley M Martin J et al. The development and evaluation of an oncological palliative care deprescribing guideline: the \u2018OncPal deprescribing guideline\u2019. Support Care Cancer 2015; 23: 71\u201378. https:\/\/doi.org\/10.1007\/s00520-014-2322-0","DOI":"10.1007\/s00520-014-2322-0"},{"key":"e_1_3_3_65_2","doi-asserted-by":"crossref","unstructured":"Morin L Laroche M-L Vetrano DL et al. Adequate questionable and inadequate drug prescribing for older adults at the end of life: a European expert consensus. Eur J Clin Pharmacol 2018; 74: 1333\u20131342. https:\/\/doi.org\/10.1007\/s00228-018-2507-4","DOI":"10.1007\/s00228-018-2507-4"},{"key":"e_1_3_3_66_2","doi-asserted-by":"crossref","unstructured":"Anlay DZ Paque K Van Den Eynden B et al. International deprescribing guidelines did not impact actual practice in deprescribing of potentially inappropriate medications for nursing home residents: an interrupted time series analysis. Drugs Aging 2025; 42: 485\u2013499. https:\/\/doi.org\/10.1007\/s40266-025-01197-2","DOI":"10.1007\/s40266-025-01197-2"},{"key":"e_1_3_3_67_2","doi-asserted-by":"crossref","unstructured":"Lavan AH Gallagher P O\u2019Mahony D. Inter-rater reliability of STOPPFrail [Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy] criteria amongst 12 physicians. Eur J Clin Pharmacol 2018; 74: 331\u2013338. https:\/\/doi.org\/10.1007\/s00228-017-2376-2","DOI":"10.1007\/s00228-017-2376-2"},{"key":"e_1_3_3_68_2","doi-asserted-by":"crossref","unstructured":"Bregnh\u00f8j L Thirstrup S Kristensen MB et al. Combined intervention programme reduces inappropriate prescribing in elderly patients exposed to polypharmacy in primary care. Eur J Clin Pharmacol 2009; 65: 199\u2013207. https:\/\/doi.org\/10.1007\/s00228-008-0558-7","DOI":"10.1007\/s00228-008-0558-7"},{"key":"e_1_3_3_69_2","doi-asserted-by":"crossref","unstructured":"Dreischulte T Donnan P Grant A et al. Safer prescribing\u2014a trial of education informatics and financial incentives. N Engl J Med 2016; 374: 1053\u20131064. https:\/\/doi.org\/10.1056\/NEJMsa1508955","DOI":"10.1056\/NEJMsa1508955"},{"key":"e_1_3_3_70_2","doi-asserted-by":"crossref","unstructured":"Murthi J Langford M Abdallah L. Impact of an educational deprescribing intervention on provider confidence knowledge and polypharmacy in the nursing home setting. J Hosp Palliat Nurs 2025; 27: 20\u201326. https:\/\/doi.org\/10.1097\/njh.0000000000001068","DOI":"10.1097\/NJH.0000000000001068"},{"key":"e_1_3_3_71_2","doi-asserted-by":"crossref","unstructured":"Djatche L Singer D Heyer A et al. How can we effectively engage physicians in the deprescribing process? Am J Med Qual 2017; 32: 581\u2013582. https:\/\/doi.org\/10.1177\/1062860617704899","DOI":"10.1177\/1062860617704899"},{"key":"e_1_3_3_72_2","doi-asserted-by":"crossref","unstructured":"Edey R Edwards N Von Sychowski J et al. Impact of deprescribing rounds on discharge prescriptions: an interventional trial. Int J Clin Pharm 2019; 41: 159\u2013166. https:\/\/doi.org\/10.1007\/s11096-018-0753-2","DOI":"10.1007\/s11096-018-0753-2"},{"key":"e_1_3_3_73_2","doi-asserted-by":"crossref","unstructured":"McCarthy C Pericin I Smith SM et al. Patient and general practitioner experiences of implementing a medication review intervention in older people with multimorbidity: process evaluation of the SPPiRE trial. Health Expect 2022; 25: 3225\u20133237. https:\/\/doi.org\/10.1111\/hex.13630","DOI":"10.1111\/hex.13630"},{"key":"e_1_3_3_74_2","doi-asserted-by":"crossref","unstructured":"Reeve E Shakib S Hendrix I et al. Review of deprescribing processes and development of an evidence-based patient-centred deprescribing process. Br J Clin Pharmacol 2014; 78: 738\u2013747. https:\/\/doi.org\/10.1111\/bcp.12386","DOI":"10.1111\/bcp.12386"},{"key":"e_1_3_3_75_2","doi-asserted-by":"crossref","unstructured":"Hilmer SN Sawan MJ. Discussion of patients\u2019 goals for pharmaceutical care is central to managing polypharmacy J Pharm Pract Res 2018; 48: 402\u2013404. https:\/\/doi.org\/10.1002\/jppr.1499","DOI":"10.1002\/jppr.1499"},{"key":"e_1_3_3_76_2","doi-asserted-by":"crossref","unstructured":"Scott IA Hilmer SN Reeve E et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med 2015; 175: 827\u2013834. https:\/\/doi.org\/10.1001\/jamainternmed.2015.0324","DOI":"10.1001\/jamainternmed.2015.0324"},{"key":"e_1_3_3_77_2","doi-asserted-by":"crossref","unstructured":"Brokaar EJ Visser LE Van Den Bos F et al. Medication optimization in older adults with advanced cancer and a limited life expectancy: a prospective observational study. J Geriatr Oncol 2023; 14: 101606. https:\/\/doi.org\/10.1016\/j.jgo.2023.101606","DOI":"10.1016\/j.jgo.2023.101606"},{"key":"e_1_3_3_78_2","doi-asserted-by":"crossref","unstructured":"McAdam C O\u2019Dwyer E Dalton K. Pharmacist-led deprescribing interventions for cancer patients in a specialist palliative care setting. Support Care Cancer 2025; 33: 321. https:\/\/doi.org\/10.1007\/s00520-025-09341-9","DOI":"10.1007\/s00520-025-09341-9"},{"key":"e_1_3_3_79_2","doi-asserted-by":"crossref","unstructured":"Masnoon N Lo S Baysari M et al. Consumer and multidisciplinary clinician experiences after implementation of the Drug Burden Index intervention bundle to facilitate deprescribing in older inpatients: a mixed method study. J Eval Clin Pract 2025; 31: e14220. https:\/\/doi.org\/10.1111\/jep.14220","DOI":"10.1111\/jep.14220"},{"key":"e_1_3_3_80_2","doi-asserted-by":"crossref","unstructured":"Geijteman ECT Van Gelder T Van Zuylen L. Sense and nonsense of treatment of comorbid diseases in terminally ill patients. JAMA Intern Med 2015; 175: 346. https:\/\/doi.org\/10.1001\/jamainternmed.2014.7592","DOI":"10.1001\/jamainternmed.2014.7592"},{"key":"e_1_3_3_81_2","doi-asserted-by":"crossref","unstructured":"Tannenbaum C Martin P Tamblyn R et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education. JAMA Intern Med 2014; 174: 890. https:\/\/doi.org\/10.1001\/jamainternmed.2014.949","DOI":"10.1001\/jamainternmed.2014.949"},{"key":"e_1_3_3_82_2","doi-asserted-by":"crossref","unstructured":"Pendergast J Wormwood JB Stolzmann K et al. Engaging patients in discussions about medication deprescribing. J Gen Intern Med 2025; 40: 1811\u20131819. https:\/\/doi.org\/10.1007\/s11606-024-09346-w","DOI":"10.1007\/s11606-024-09346-w"},{"key":"e_1_3_3_83_2","doi-asserted-by":"crossref","unstructured":"Martin P Tamblyn R Benedetti A et al. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial. JAMA 2018; 320: 1889\u20131898. https:\/\/doi.org\/10.1001\/jama.2018.16131","DOI":"10.1001\/jama.2018.16131"},{"key":"e_1_3_3_84_2","doi-asserted-by":"crossref","unstructured":"Jones KF Stolzmann K Wormwood J et al. Patient-directed education to promote deprescribing. JAMA Intern Med 2024; 184: 1339. https:\/\/doi.org\/10.1001\/jamainternmed.2024.4739","DOI":"10.1001\/jamainternmed.2024.4739"},{"key":"e_1_3_3_85_2","doi-asserted-by":"crossref","unstructured":"Baumgartner AD Clark CM Lavalley SA et al. Interventions to deprescribe potentially inappropriate medications in the elderly: lost in translation? J Clin Pharm Ther 2020; 45: 453\u2013461. https:\/\/doi.org\/10.1111\/jcpt.13103","DOI":"10.1111\/jcpt.13103"},{"key":"e_1_3_3_86_2","doi-asserted-by":"crossref","unstructured":"Al-Babtain B Cheema E Hadi MA. Impact of community-pharmacist-led medication review programmes on patient outcomes: a systematic review and meta-analysis of randomised controlled trials. Res Social Adm Pharm 2022; 18: 2559\u20132568. https:\/\/doi.org\/10.1016\/j.sapharm.2021.04.022","DOI":"10.1016\/j.sapharm.2021.04.022"},{"key":"e_1_3_3_87_2","doi-asserted-by":"crossref","unstructured":"Dills H Shah K Messinger-Rapport B et al. Deprescribing medications for chronic diseases management in primary care settings: a systematic review of randomized controlled trials. J Am Med Dir Assoc 2018; 19: 923\u2013935.e922. https:\/\/doi.org\/10.1016\/j.jamda.2018.06.021","DOI":"10.1016\/j.jamda.2018.06.021"},{"key":"e_1_3_3_88_2","doi-asserted-by":"crossref","unstructured":"Birke H J\u00f8rgensen SM Lech LVJ et al. DEprescribing and Care to reduce Antipsychotics in DEmentia (DECADE)-a hybrid effectiveness-implementation pilot study. Am J Geriatr Psychiatry 2025; 33: 730\u2013745. https:\/\/doi.org\/10.1016\/j.jagp.2025.03.012","DOI":"10.1016\/j.jagp.2025.03.012"},{"key":"e_1_3_3_89_2","doi-asserted-by":"crossref","unstructured":"van der Steen JT Engels Y Touwen DP et al. Advance care planning in the Netherlands. Z Evid Fortbild Qual Gesundhwes 2023; 180: 133\u2013138. https:\/\/doi.org\/10.1016\/j.zefq.2023.06.003","DOI":"10.1016\/j.zefq.2023.06.003"},{"key":"e_1_3_3_90_2","article-title":"Adjusting medication at the end of life: towards optimalisation of healthcare in the final fase of life","volume":"165","author":"Geijteman ECT","year":"2021","unstructured":"Geijteman ECT, Elsten E, van der Kuy P, et al. Adjusting medication at the end of life: towards optimalisation of healthcare in the final fase of life. Ned Tijdschr Geneeskd 2021; 165: D6193.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_3_3_91_2","unstructured":"Palliaweb. Indicatorenset voor de palliatieve zorg https:\/\/palliaweb.nl\/publicaties\/indicatorenset-voor-de-palliatieve-zorg (2023 accessed 10 December 2025)."},{"key":"e_1_3_3_92_2","doi-asserted-by":"crossref","unstructured":"Nizet P Evin A Brociero E et al. Outcomes in deprescribing implementation trials and compliance with expert recommendations: a systematic review. BMC Geriatr 2023; 23: 428. https:\/\/doi.org\/10.1186\/s12877-023-04155-y","DOI":"10.1186\/s12877-023-04155-y"}],"container-title":["Palliative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02692163261465769","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02692163261465769","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02692163261465769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:02:04Z","timestamp":1792486924000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02692163261465769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":91,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1177\/02692163261465769"],"URL":"https:\/\/doi.org\/10.1177\/02692163261465769","relation":{},"ISSN":["0269-2163","1477-030X"],"issn-type":[{"value":"0269-2163","type":"print"},{"value":"1477-030X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}